[go: up one dir, main page]

WO2000056266A3 - Compositions d'enrobage masquant le gout - Google Patents

Compositions d'enrobage masquant le gout Download PDF

Info

Publication number
WO2000056266A3
WO2000056266A3 PCT/IB1999/001735 IB9901735W WO0056266A3 WO 2000056266 A3 WO2000056266 A3 WO 2000056266A3 IB 9901735 W IB9901735 W IB 9901735W WO 0056266 A3 WO0056266 A3 WO 0056266A3
Authority
WO
WIPO (PCT)
Prior art keywords
coating compositions
taste masking
masking coating
composition
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB1999/001735
Other languages
English (en)
Other versions
WO2000056266A2 (fr
Inventor
Gour Mukherji
Manoj Kumar
Himadri Sen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Priority to EP99949283A priority Critical patent/EP1235556A4/fr
Priority to AU62246/99A priority patent/AU6224699A/en
Priority to BR9917219-4A priority patent/BR9917219A/pt
Publication of WO2000056266A2 publication Critical patent/WO2000056266A2/fr
Anticipated expiration legal-status Critical
Publication of WO2000056266A3 publication Critical patent/WO2000056266A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une composition d'enrobage à utiliser pour le pelliculage de noyaux pharmaceutiques contenant le médicament. Ladite composition comprend un matériau filmogène combiné à un polymère gonflant de haute viscosité.
PCT/IB1999/001735 1999-03-19 1999-10-26 Compositions d'enrobage masquant le gout Ceased WO2000056266A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP99949283A EP1235556A4 (fr) 1999-03-19 1999-10-26 Compositions d'enrobage masquant le gout
AU62246/99A AU6224699A (en) 1999-03-19 1999-10-26 Taste masking coating compositions
BR9917219-4A BR9917219A (pt) 1999-03-19 1999-10-26 Composições de revestimento para mascaramento de sabor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN454DE1999 IN191482B (fr) 1999-03-19 1999-03-19
IN454/DEL/99 1999-03-19

Publications (2)

Publication Number Publication Date
WO2000056266A2 WO2000056266A2 (fr) 2000-09-28
WO2000056266A3 true WO2000056266A3 (fr) 2002-07-04

Family

ID=11089863

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1999/001735 Ceased WO2000056266A2 (fr) 1999-03-19 1999-10-26 Compositions d'enrobage masquant le gout

Country Status (7)

Country Link
EP (1) EP1235556A4 (fr)
CN (1) CN1615121A (fr)
AU (1) AU6224699A (fr)
BR (1) BR9917219A (fr)
IN (1) IN191482B (fr)
WO (1) WO2000056266A2 (fr)
ZA (1) ZA200007724B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN191239B (fr) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US20030039687A1 (en) * 2001-08-01 2003-02-27 Michael Corbo Taste masking composition
ATE536173T1 (de) 2002-02-21 2011-12-15 Biovail Lab Int Srl Formulierungen mit modifizierter freisetzung von mindestens einer form von tramadol
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US8889184B2 (en) * 2006-09-07 2014-11-18 Losan Pharma Gmbh Particulate form of a pharmaceutical composition which is easy to swallow

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
EP0650353B1 (fr) * 1992-06-04 2002-05-22 Smithkline Beecham Corporation Compositions pharmaceutiques au gout agreable
DE19709532A1 (de) * 1997-03-10 1998-09-17 Basf Ag Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1235556A4 *

Also Published As

Publication number Publication date
AU6224699A (en) 2000-10-09
EP1235556A2 (fr) 2002-09-04
CN1615121A (zh) 2005-05-11
ZA200007724B (en) 2002-06-12
IN191482B (fr) 2003-12-06
WO2000056266A2 (fr) 2000-09-28
EP1235556A4 (fr) 2003-07-16
BR9917219A (pt) 2002-04-23

Similar Documents

Publication Publication Date Title
EP0839527A3 (fr) Comprimés enrobés par un film et ayant des caractéristiques de désintégration améliorées
WO2002072033A3 (fr) Formes pharmaceutiques chronotherapeutiques contenant un glucocorticosteroide
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
CA2312710A1 (fr) Formulation a liberation prolongee contenant trois types differents de polymeres et comprime prepare a partir de cette formulation
WO2004054542A3 (fr) Systeme d'administration de medicaments par voie orale
MXPA02000277A (es) Particulas de encubrimiento de textura que contienen un ingrediente activo.
WO2001041737A3 (fr) Forme de dosage oral solide
CA2265651A1 (fr) Film hydrosoluble ou couche hydrosoluble a mouillabilite immediate pour application orale
CA2326137A1 (fr) Procede de stabilisation de compositions pharmaceutiques par utilisation speciale d'un antioxydant
WO2002000171A3 (fr) Preparation de diffusion d'un facteur de croissance hematopoietique
EP0815853A3 (fr) Préparation à libération soutenue pour substance active à groupe acide
EP1050538A3 (fr) Compositions de silicones réticulables par irradiation contenant des composés de platine photoactifs
AU3268789A (en) Osmotic continuous dispensing oral delivery system containing pharmaceutically acceptable active agent having improved core membrane adhesion properties
WO2002011702A3 (fr) Forme posologique de medicament entraine par un hydrogel
IL149572A0 (en) Film preparation for biphasic release of pharmacologically active or other substances
CA2359872A1 (fr) Gels formes par l'interaction d'un poly(aldehyde) avec diverses substances
AU3877000A (en) Allyl compounds, compositions containing allyl compounds and processes for forming and curing polymer compositions
WO2005027843A3 (fr) Formes de dosage chronotherapeutique
WO2005097064A3 (fr) Medicaments au gout masque lors de la rupture des matieres particulaires multiples
WO2006067096A8 (fr) Emballage en feuilles
AU4096799A (en) Very high viscosity polyvinylsiloxane impression material
WO2001041742A3 (fr) Medication antivirale
AU4302100A (en) Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
WO2000056266A3 (fr) Compositions d'enrobage masquant le gout

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99816588.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 514297

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1999949283

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 62246/99

Country of ref document: AU

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09936934

Country of ref document: US

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 1999949283

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999949283

Country of ref document: EP